Mesoporous europo-gadolinosilicate nanoparticles as bimodal medical imaging agents and a potential theranostic platform

Nicholas M K Tse, Danielle F. Kennedy*, Nigel Kirby, Bradford A. Moffat, Benjamin W. Muir, Rachel A. Caruso, Calum J. Drummond

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The mesoporous structure of sol-gel prepared gadolinium and europium doped silicate nanoparticles has been found to be highly dependent on the formulated composition, with synthesised samples displaying both disordered and hexagonally ordered mesoporous packing symmetry. The degree of pore ordering within the nanoparticles has a strong correlation with the total lanthanide (Gd3+ and Eu3+) concentration. The gadolinosilicates are excellent magnetic resonance imaging (MRI) longitudinal (T1) agents. The longitudinal relaxivity (r1) and transverse (r2) relaxivity, a measure of MRI contrast agent efficiency, were up to four times higher than the clinically employed Omniscan (gadodiamide); with r1 up to 20.6 s-1 mM-1 and r2 of 66.2 s-1 mM-1 compared to 5.53 and 4.64 s-1 mM-1, respectively, for Omniscan. In addition, the europium content of all the samples studied is below the self-quenching limit, which results in a strong luminescence response from the nanoparticles on excitation at 250 nm. The Eu-Gd silicate nanoparticles act as bimodal imaging agents for MRI and luminescence. These mesoporous nanoparticles also have the potential to serve as encapsulation and controlled release matrices for pharmaceuticals. They are therefore a promising multimodal theranostic platform.

Original languageEnglish
Pages (from-to)836-845
Number of pages10
JournalAdvanced Healthcare Materials
Volume2
Issue number6
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'Mesoporous europo-gadolinosilicate nanoparticles as bimodal medical imaging agents and a potential theranostic platform'. Together they form a unique fingerprint.

Cite this